Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
about
A possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathyPotential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in AfricaRepurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathyRepurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasisEffect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled TrialUsing Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination ProgramsCase report: Loiasis with peripheral nerve involvement and spleen lesionsEosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas.Clinical Features of Imported Loiasis: A Case Series from the Hospital for Tropical Diseases, London.Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.Ivermectin: does P-glycoprotein play a role in neurotoxicity?Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa.Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa
P2860
Q28217814-EEE3110E-AE9E-4AEA-96BA-E4AD72431277Q28468413-58EDF644-862B-402D-87F4-21489BEC0F7AQ28543058-11370058-94D2-4E8B-A8FC-7FA225A3D11FQ28543559-703A0B2C-81E2-47C7-8F86-A0DDD5C07496Q28550715-A055454D-63A2-48A2-AB95-9267F9B5DE26Q28554765-CD0172F1-434F-489E-ADFA-4466177B3805Q34875613-0CB0E861-DE33-4EBE-A8A9-DF9D6748B074Q34974564-9E42BE71-FC1E-4CD1-B3C6-78378C25BB6BQ36026551-7E3EA1B3-4101-4C39-BE16-2BD99A249957Q39065670-4C352D9A-D16B-4D49-B877-16139AFDE5ECQ42102770-4C8F9408-BFAA-4647-9CC2-CF9D0007399FQ42854140-7C18FE10-3E93-44C6-87E0-A22325F8767CQ53069763-07B90B23-56D5-4400-B0A2-5C7E72E4A19EQ58723511-7ABF5AE3-ED15-4B0C-89D3-90B121D839E7
P2860
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@ast
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@en
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@nl
type
label
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@ast
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@en
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@nl
prefLabel
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@ast
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@en
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@nl
P2093
P1476
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine
@en
P2093
J Boulesteix
M F Puruehnce
P304
P407
P577
1991-06-01T00:00:00Z